Movement Alert｜TRANSTHERA-B Rises 8.83% in Regular Trading, Innovative Drug Sector Rally Combined with Intensive Share Buybacks

Market Focus08-05

On August 5, TRANSTHERA-B rose 8.83% in regular trading, trading at 12.64 HKD/share, with turnover of approximately 84.27 million HKD, extending the strong rebound from the previous session.

On the news front, the Hong Kong-listed innovative drug sector has been collectively strengthening in recent days, with southbound capital continuously adding positions in innovative drug targets and foreign capital also allocating to the sector. At the company level, TRANSTHERA-B has been intensively repurchasing H shares since July, accumulating 718,000 shares bought back during the month for a total expenditure exceeding 7 million HKD, signaling management confidence in the company's intrinsic value. Additionally, on July 24 the company granted approximately 5.259 million H share incentives to 67 employees, including 2.817 million share awards and 2.442 million share options, further aligning core team interests with shareholders.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1163773660?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 09:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163773660","market":"hk","top_or_hot":-1,"title":"Movement Alert｜TRANSTHERA-B Rises 8.83% in Regular Trading, Innovative Drug Sector Rally Combined with Intensive Share Buybacks","media":"Market Focus","content":"<p><p>On August 5, TRANSTHERA-B rose 8.83% in regular trading, trading at 12.64 HKD/share, with turnover of approximately 84.27 million HKD, extending the strong rebound from the previous session.</p><p>On the news front, the Hong Kong-listed innovative drug sector has been collectively strengthening in recent days, with southbound capital continuously adding positions in innovative drug targets and foreign capital also allocating to the sector. At the company level, TRANSTHERA-B has been intensively repurchasing H shares since July, accumulating 718,000 shares bought back during the month for a total expenditure exceeding 7 million HKD, signaling management confidence in the company's intrinsic value. Additionally, on July 24 the company granted approximately 5.259 million H share incentives to 67 employees, including 2.817 million share awards and 2.442 million share options, further aligning core team interests with shareholders.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜TRANSTHERA-B Rises 8.83% in Regular Trading, Innovative Drug Sector Rally Combined with Intensive Share Buybacks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜TRANSTHERA-B Rises 8.83% in Regular Trading, Innovative Drug Sector Rally Combined with Intensive Share Buybacks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-05 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 5, TRANSTHERA-B rose 8.83% in regular trading, trading at 12.64 HKD/share, with turnover of approximately 84.27 million HKD, extending the strong rebound from the previous session.</p><p>On the news front, the Hong Kong-listed innovative drug sector has been collectively strengthening in recent days, with southbound capital continuously adding positions in innovative drug targets and foreign capital also allocating to the sector. At the company level, TRANSTHERA-B has been intensively repurchasing H shares since July, accumulating 718,000 shares bought back during the month for a total expenditure exceeding 7 million HKD, signaling management confidence in the company's intrinsic value. Additionally, on July 24 the company granted approximately 5.259 million H share incentives to 67 employees, including 2.817 million share awards and 2.442 million share options, further aligning core team interests with shareholders.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02617","symbol_name":"药捷安康-B","start_time":0,"source_url":"","article_id":"1163773660","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163773660","pubTimestamp":1785894799,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 5, TRANSTHERA-B rose 8.83% in regular trading, trading at 12.64 HKD/share, with turnover of approximately 84.27 million HKD, extending the strong rebound from the previous session.On the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02617":"药捷安康-B"},"translate_title":"走势提醒|TRANSTHERA-B 常规交易上涨 8.83%，创新药板块反弹叠加密集股票回购","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02617":1},"content_text":"On August 5, TRANSTHERA-B rose 8.83% in regular trading, trading at 12.64 HKD/share, with turnover of approximately 84.27 million HKD, extending the strong rebound from the previous session.On the news front, the Hong Kong-listed innovative drug sector has been collectively strengthening in recent days, with southbound capital continuously adding positions in innovative drug targets and foreign capital also allocating to the sector. At the company level, TRANSTHERA-B has been intensively repurchasing H shares since July, accumulating 718,000 shares bought back during the month for a total expenditure exceeding 7 million HKD, signaling management confidence in the company's intrinsic value. Additionally, on July 24 the company granted approximately 5.259 million H share incentives to 67 employees, including 2.817 million share awards and 2.442 million share options, further aligning core team interests with shareholders.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1163773660","isCrawlerRequest":true}